CALGB

CALGB (click for all protocols, scroll to the appropriate protocol)

59903 A Randomized Phase III Trial Comparing Early High Dose ChemoradiotherapyAnd An Autologous Stem Cell Transplant To Conventional Dose CHOP Chemotherapy Plus RituximubFor CD20+ B Cell Lymphomas (With Possible Late AutologousStem Cell Transplant) For Patients With Diffuse Aggressive Non-Hodgkin’s Lymphoma In The High-Intermediate and High Risk International Classification Prognostic Groups (A BMT Study)
Status: Active Enrolling
PI: Bruce A Peterson, MD
Data Collector: Jane Gau, RN, 612 625 9125